Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001628280-26-004866

Director sold 22,000 shares at $7.71 ($169,671)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
SATO VICKI L Director 2026-02-02 Sale 10b5-1 −22,000 $7.71 $169,671 1,144,391 D
Open-market sales · 22,000 sh · avg $7.71 · $169,671
Loading xslF345X05/wk-form4_1770139722.xml…